Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Human Vaccines & Immunotherapeutics Année : 2020

Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries

Résumé

In France, the incidence of invasive meningococcal disease (IMD) is around 1/100,000, with the following trends over the 2011–2018 period: a leading role of group B in subjects <15 years, a decrease of group C among <1 year since 2017, an increase of group W in all age groups including subjects <1 year since 2014 and a positive correlation between group Y and age group. In Europe, vaccination progressed with conjugate ACWY vaccines and proteins-based B vaccines. Their benefit-risk-cost balance is however not so obvious for area at low incidence (<2/100,000), explaining tremendous variations between countries, from no recommendation to recommend all available vaccines. In France, the calendar still includes only C with a good adhesion in infants but a fiasco of the catch-up campaign in adolescents and young adults. In Europe, it is time to consider not only national epidemiology but also trends in the neighborhood. The increase of group W cases encourages switching C to ACWY vaccine both in infants and adolescents. It is also time to protect infants with B vaccine. Large pedagogy on the disease is required to increase the adhesion to the vaccination and to recognize and treat earlier the residual cases.
Fichier principal
Vignette du fichier
Recent changes of invasive meningococcal disease in France arguments to revise the vaccination strategy in view of those of other countries.pdf (1.24 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

pasteur-02618644 , version 1 (25-05-2020)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Muhamed-Kheir Taha, Joel Gaudelus, Ala-Eddine Deghmane, Francois Caron. Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries. Human Vaccines & Immunotherapeutics, 2020, 16 (10), pp.2518-2523. ⟨10.1080/21645515.2020.1729030⟩. ⟨pasteur-02618644⟩
41 Consultations
105 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More